Apr 21, 2026 06:35AM
Jan 30, 2026 04:16AM
Sep 16, 2025 09:42AM
Mar 27, 2025 09:24AM
Jun 13, 2022 04:54PM
May 23, 2022 08:30AM
May 23, 2022 08:30AM Royalty Pharma to Present at the UBS Global Healthcare Conference 2022
Jan 18, 2022 07:01AM
Jan 18, 2022 07:00AM
Jan 19, 2021 09:27AM
Nov 9, 2020 05:46AM
Oct 20, 2020 04:32PM
Oct 20, 2020 04:32PM
Oct 16, 2020 05:47AM Royalty Pharma plc (RPRX) Prices 17.34M Class A Share Secondary Offering at $42/Sh by Selling Shareholders
Oct 15, 2020 11:45PM
Oct 15, 2020 11:45PM
Oct 13, 2020 04:11PM
Oct 13, 2020 04:10PM
Oct 13, 2020 04:10PM
Jul 13, 2020 04:21AM
Jun 18, 2020 04:15PM Royalty Pharma Announces Closing of Initial Public Offering
Jun 18, 2020 04:15PM
Jun 16, 2020 12:07PM
Dec 12, 2017 09:27AM
Jun 2, 2016 09:26AM
Apr 13, 2016 09:33AM
Sep 18, 2014 12:10PM
Aug 17, 2009 09:15AM Repros Therapeutics (RPRX) Reports Wider-Than-Expected Q2 Loss of $0.59; Receives Notices from FDA, Nasdaq
Jul 27, 2009 12:37PM
Jul 23, 2009 12:15PM

169,653 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All